Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

BackgroundIMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) showed that adding the nonstatin ezetimibe to statin therapy further reduced cardiovascular events in patients after an acute coronary syndrome. In a prespecified analysis, we explore results stratified by se...

Descripció completa

Dades bibliogràfiques

Autors principals:	Eri Toda Kato, Christopher P. Cannon, Michael A. Blazing, Erin Bohula, Sema Guneri, Jennifer A. White, Sabina A. Murphy, Jeong‐Gun Park, Eugene Braunwald, Robert P. Giugliano
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2017-11-01
Col·lecció:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:	cholesterol chronic ischemic heart disease coronary artery disease ezetimibe lipids and lipoprotein metabolism secondary prevention
Accés en línia:	https://www.ahajournals.org/doi/10.1161/JAHA.117.006901
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!